淳厚欣享A(009931)近一年回报达14.36%，淳厚基金调研上市公司广誉远

Group 1 - The company has shifted its management approach from "strong control" to "strong operation," emphasizing growth as the primary goal and enhancing operational efficiency [2] - Recent management adjustments have led to a consensus on promoting growth, resulting in improved decision-making and sales performance across various product lines [2] - The company has successfully navigated economic downturns and industry pressures by leveraging strong product efficacy and effective marketing strategies [2] Group 2 - All four core products and business divisions have shown growth, with the An Gong series stabilizing after a decline in 2024, and the Gui Ling Gao regaining its status as a core product [2] - The company is actively addressing the impact of healthcare policies on its products, particularly focusing on optimizing product strategies and enhancing market research [2] - Brand promotion efforts are being intensified through collaborations with authoritative media and research institutions, aiming to enhance marketing effectiveness and academic support for products [2] Group 3 - The company is focused on improving operational quality and market share, with internal performance metrics aligned with growth objectives [3] - The company has established a market value management system in response to regulatory requirements, emphasizing communication with investors and proactive management of stock price fluctuations [3]